Chemotherapy News and Research

Latest Chemotherapy News and Research

Integrating PGx testing for personalized prostate cancer treatment

Integrating PGx testing for personalized prostate cancer treatment

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

Breakthrough CAR T therapy and shorter targeted therapy durations offer hope for patients with leukemia

Breakthrough CAR T therapy and shorter targeted therapy durations offer hope for patients with leukemia

Polygenic risk score shows potential to predict survival outcomes in breast cancer patients

Polygenic risk score shows potential to predict survival outcomes in breast cancer patients

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

New surgical platform informs critical decision-making about tumor treatment within minutes

New surgical platform informs critical decision-making about tumor treatment within minutes

New molecular analysis unravels the biological mechanisms of pediatric brain tumors

New molecular analysis unravels the biological mechanisms of pediatric brain tumors

New weapon against cancer: "DNA warhead" targets mutant protein in tumor cells

New weapon against cancer: "DNA warhead" targets mutant protein in tumor cells

Novel method predicts cancer cell behaviors using nano informatics and machine learning

Novel method predicts cancer cell behaviors using nano informatics and machine learning

New type of immunotherapy shows promising preclinical results against osteosarcoma

New type of immunotherapy shows promising preclinical results against osteosarcoma

New ultrasound method reveals minute vascular structures using contrast agents

New ultrasound method reveals minute vascular structures using contrast agents

Proline-based nano cages offer targeted drug delivery, limit side effects of chemotherapy

Proline-based nano cages offer targeted drug delivery, limit side effects of chemotherapy

MUSC researchers unravel the mystery of cancer recurrence

MUSC researchers unravel the mystery of cancer recurrence

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

AI-based body composition analysis predicts lung cancer treatment outcomes

AI-based body composition analysis predicts lung cancer treatment outcomes

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

Biological similarities found between "chemo brain" and brain fog after COVID-19

Biological similarities found between "chemo brain" and brain fog after COVID-19

Tailored antibody-drug conjugate offers hope for aggressive breast cancer

Tailored antibody-drug conjugate offers hope for aggressive breast cancer

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

Study identifies PI3K-beta as key target in overcoming chemotherapy resistance in glioblastoma

Study identifies PI3K-beta as key target in overcoming chemotherapy resistance in glioblastoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.